The Art of
Licensing
About Helsinn
• Board of Directors and Top Management
• Contacts
• News
2008
2009
2010
Our locations
• Switzerland
• Ireland
• USA
Helsinn's recent history
The Art of
Development
Building pharmaceuticals
Our R&D
The Art of
Access
Making pharmaceuticals available
Our products
• Cancer Supportive Care
Palonosetron
Gelclair
Netupitant
Anamorelin
ZP1846
• Pain and Inflammation
Nimesulide
Oxaprozin
Rapid Absorption Platform
• Gastroenterology
Palonosetron
Klean-Prep
Ipamorelin
ST-1141
• Areas under development
Urology
The Ghrelin Family
The Art of
Manufacturing
High standard technologies
Helsinn Advanced Synthesis SA, Biasca
Helsinn Birex Pharmaceuticals Ltd, Dublin
The Art of
Partnership
Shaping alliances
• Our partners
Home
>
The Art of Access
>
Our products
>
Gastroenterology
>
ST-1141
ST-1141
An orally active ghrelin agonist for the treatment of opioid-induced bowel dysfunction.
Development status: Phase 1.
Copyright © Helsinn Group - Legal Statement
Last Update: 01.09.2010
About Helsinn
Our Products
Our Partners